Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

about

Advances on chimeric antigen receptor-modified T-cell therapy for oncotherapy.Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

P2860

Q54979818-7DB1DC6C-A591-4F8D-A6F0-71B2BB8D352D Q58786421-F30616E0-516B-4A42-A00E-55B972DA637A

P2860

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

Item

http://www.wikidata.org/entity/Q52646462

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@en

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@nl

type

Item

label

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@en

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@nl

prefLabel

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@en

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@nl

P1476

Accurate control of dual-recep ...... ional anti-angiogenic peptide.

@en

P2093

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Chenyu Lin

http://www.w3.org/2001/XMLSchema#string

Erhao Zhang

http://www.w3.org/2001/XMLSchema#string

Hanmei Xu

http://www.w3.org/2001/XMLSchema#string

Jialiang Hu

http://www.w3.org/2001/XMLSchema#string

Jianpeng Xue

http://www.w3.org/2001/XMLSchema#string

Jieyi Gu

http://www.w3.org/2001/XMLSchema#string

Jingchao Hao

http://www.w3.org/2001/XMLSchema#string

Mengwei Li

http://www.w3.org/2001/XMLSchema#string

Sarra Setrerrahmane

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Challenges to chimeric antigen receptor (CAR)-T cell therapy for cancer

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.

Chimeric antigen receptor T cells for sustained remissions in leukemia

Inducible apoptosis as a safety switch for adoptive cell therapy

Cancer immunotherapy comes of age

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia

CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

P2888

s13045-018-0591-7

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-018-0591-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101632943

http://www.w3.org/2001/XMLSchema#string

P698

29558951

http://www.w3.org/2001/XMLSchema#string

P932

5859748

http://www.w3.org/2001/XMLSchema#string

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

about

P2860

P2860

Accurate control of dual-receptor-engineered T cell activity through a bifunctional anti-angiogenic peptide.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932